Expansion Opportunity Strong focus on turnkey, modular radiation shielding solutions and recent collaboration with NorthStar Medical Radioisotopes to expand in the industrial radiopharmaceutical manufacturing segment. Target radiopharm manufacturers and cancer treatment centers seeking scalable, pre-engineered shielding facilities.

Market Position Global leadership in design, production, and installation of pre-engineered shielding facilities with applications across radiotherapy, oncology, radiopharmaceutical manufacturing, and medical imaging. Position Veritas as a single-source supplier for shielding needs across multiple high-demand sectors.

Financial Capacity Reported annual revenue in the mid-range of tens of millions (25–50M) with a mid-sized employee base, suggesting capacity for mid to large scale projects and potential for long‑term contracts with healthcare systems and manufacturing partners.

Strategic Partnerships Recent alliance with NorthStar Medical Radioisotopes indicates a channel to access growing isotope production markets and joint opportunities in shielding facilities for radiopharmacy manufacturing, presenting a credible entry point for co‑selling and bundled solutions.

Target Customer Profile Primary customers likely include hospitals, radiotherapy centers, oncology facilities, radiopharmaceutical manufacturers, and industrial inspection firms. Focus on facilities needing turnkey shielding solutions, rapid deployment, and cost-efficient modular designs to accelerate project timelines.